Nipro Corporation

Informe acción TSE:8086

Capitalización de mercado: JP¥228.3b

Nipro Dirección

Dirección controles de criterios 2/4

El CEO de Nipro es Yoshihiko Sano, nombrado en May 2012, tiene una permanencia de 12.5 años. posee directamente un 0.068% de las acciones de la empresa, con un valor de ¥155.61M. La antigüedad media del equipo directivo y de la junta directiva es de 10.6 años y 15.4 años, respectivamente.

Información clave

Yoshihiko Sano

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO12.5yrs
Participación del CEO0.07%
Permanencia media de la dirección10.6yrs
Promedio de permanencia en la Junta Directiva15.4yrs

Actualizaciones recientes de la dirección

Recent updates

Market Participants Recognise Nipro Corporation's (TSE:8086) Earnings

Oct 16
Market Participants Recognise Nipro Corporation's (TSE:8086) Earnings

These 4 Measures Indicate That Nipro (TSE:8086) Is Using Debt In A Risky Way

Sep 28
These 4 Measures Indicate That Nipro (TSE:8086) Is Using Debt In A Risky Way

Nipro's (TSE:8086) Dividend Will Be ¥12.00

Aug 30
Nipro's (TSE:8086) Dividend Will Be ¥12.00

Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00

Jul 25
Nipro (TSE:8086) Has Announced A Dividend Of ¥12.00

Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00

Jul 11
Nipro (TSE:8086) Will Pay A Dividend Of ¥12.00

Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet

Jun 06
Nipro (TSE:8086) Has A Somewhat Strained Balance Sheet

Earnings Tell The Story For Nipro Corporation (TSE:8086)

Apr 02
Earnings Tell The Story For Nipro Corporation (TSE:8086)

Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00

Feb 27
Nipro (TSE:8086) Will Pay A Larger Dividend Than Last Year At ¥15.00

CEO

Yoshihiko Sano (79 yo)

12.5yrs

Permanencia

Mr. Yoshihiko Sano serves as President since May 2012 and Representative Director of Nipro Corporation. Mr. Sano served as Managing Director of Nipro Corporation since June 2006 until May 2012. He is Chair...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Yoshihiko Sano
Chairman of Board & President12.5yrssin datos0.068%
¥ 155.6m
Akihiko Yamabe
Manager of Accounting Department - Corporate Planning Division10.3yrssin datossin datos
Hideto Nakamura
GM of General Affairs10.3yrssin datos0.015%
¥ 35.3m
Kiyotaka Yoshioka
Senior MD12.4yrssin datos0.0061%
¥ 14.0m
Toshiaki Masuda
MD, Head of Planning and Development and Director9.4yrssin datos0.0084%
¥ 19.3m
Tsuyoshi Yamazaki
Senior MD9.8yrssin datos0.011%
¥ 25.7m
Kimihito Minoura
MD, Head of Regenerative Medicine and Business Promotion9.4yrssin datos0.018%
¥ 41.2m
Kazuhiko Sano
MD, GM of Facilities Division & Production Technology Center and Director10.6yrssin datos0.011%
¥ 24.8m
Kenichi Nishida
MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Director12.1yrssin datos0.0037%
¥ 8.5m
Kyoetsu Kobayashi
MD, GM of the Stable Production & Crisis Management Division and Director10.6yrssin datos0.013%
¥ 28.7m
Toyoshi Yoshida
Director of Quality Assurance Division & Director13.6yrssin datos0.0094%
¥ 21.6m
Yasushi Oyama
MD, Head of Vascular Business Division & Directorno datasin datos0.012%
¥ 27.9m

10.6yrs

Permanencia media

66yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 8086 es experimentado (10.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Yoshihiko Sano
Chairman of Board & President31.8yrssin datos0.068%
¥ 155.6m
Hideto Nakamura
GM of General Affairs15.4yrssin datos0.015%
¥ 35.3m
Kiyotaka Yoshioka
Senior MD18.4yrssin datos0.0061%
¥ 14.0m
Toshiaki Masuda
MD, Head of Planning and Development and Directorno datasin datos0.0084%
¥ 19.3m
Tsuyoshi Yamazaki
Senior MDno datasin datos0.011%
¥ 25.7m
Kimihito Minoura
MD, Head of Regenerative Medicine and Business Promotion15.4yrssin datos0.018%
¥ 41.2m
Kazuhiko Sano
MD, GM of Facilities Division & Production Technology Center and Director14.4yrssin datos0.011%
¥ 24.8m
Kenichi Nishida
MD, Head of Pharmaceutical Business Division and Pharmaceutical Production & Directorno datasin datos0.0037%
¥ 8.5m
Kyoetsu Kobayashi
MD, GM of the Stable Production & Crisis Management Division and Directorno datasin datos0.013%
¥ 28.7m
Toyoshi Yoshida
Director of Quality Assurance Division & Director14.4yrssin datos0.0094%
¥ 21.6m
Yasushi Oyama
MD, Head of Vascular Business Division & Directorno datasin datos0.012%
¥ 27.9m
Takehito Yogo
Senior MD18.2yrssin datos0.0043%
¥ 9.9m

15.4yrs

Permanencia media

64yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de 8086 son experimentados ( 15.4 años antigüedad media).